Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma

European Radiology

Volumn 20, Issue 7, 2010, Pages 1703-1714

  Vandecaveye, Vincent ^a   Dirix, Piet ^a   De Keyzer, Frederik ^a   Op De Beeck, Katya ^a   Vander Poorten, Vincent ^a   Roebben, I ^a   Nuyts, Sandra ^a   Hermans, Robert ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chemoradiotherapy; Diffusion weighted MRI; Head and neck cancer; Treatment prediction; Volumetric assessment

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; LYMPH NODE METASTASIS; MALE; NECK DISSECTION; PREDICTION AND FORECASTING; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR LOCALIZATION; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; MIDDLE AGED; PREDICTIVE VALUE; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 77954818592     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-010-1734-6     Document Type: Article

References (39)

1. Ang KK, Harris J, Garden AS et al (2005) Concomitant boost radiation plus concurrent cisplatinum for advanced head and neck carcinomas: Radiation Therapy Oncology Group phase II trial 99-14. J Clin Oncol 23:3008-3015
2. Nuyts S, Dirix P, Clement P et al (2009) Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 15:1088-1095
3. Pignon JP, Bourhis, Domenge C et al (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC collaborative group. Meta analysis of chemotherapy on head and neck cancer. Lancet 18:949-955
4. Gregoire V, De Neve W, Eisbruch A et al (2007) Intensity-modulated radiation therapy for head and neck carcinoma. Oncologist 12:555-564
5. Klug C, Keszthelyi D, Ploder O et al (2004) Neoadjuvant chemoradiotherapy of oral cavity and oropharyngeal: evaluation of tumor response by CT differs from histopathologic response assessment in a significant fraction of patients. Head Neck 26:224-231
6. Denys D, Kumar P, Wong FS et al (1997) The predictive value of tumor regression rates during chemoradiation therapy in patients with advanced head and neck squamous cell carcinoma. Am J Surg 174:561-564
7. Jaulerry C, Dubray B, Brunin F et al (1995) Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study. Int J Radiat Oncol Biol Phys 33:271-279
8. Kostakoglu L, Goldsmith SJ (2004) PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med 45:56-68
9. Geets X, Tomsej M, Lee JA et al (2007) Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol 85:105-115
10. Madani I, Duthoy W, Derie C et al (2007) Positron emission tomographyguided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 68:126-135
11. Le Bihan D, Breton E, Lallemand D et al (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497-505
12. Bammer R (2003) Basic principles of diffusion-weighted MRI. Eur J Radiol 45:169-184
13. Ross BD, Moffat A, Lawrence TS et al (2003) Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther 2:581-587
14. Thoeny HC, De Keyzer F (2007) Extracranial applications of diffusion-weighted magnetic resonance imaging. Eur Radiol 17:1385-1393
15. Koh DM, Collins DJ (2007) Diffusionweighted MRI in the body: applications and challenges in oncology. Am J Roentgenol 188:1622-1635
16. Vandecaveye V, De Keyzer F, Nuyts S et al (2007) Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 67:960-971
17. Hamstra DA, Lee KC, Moffat BA et al (2008) Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck. Transl Oncol 1:187-194
18. Vandecaveye V, De Keyzer F, Hermans R (2008) Diffusion-weighted magnetic resonance imaging in neck lymph adenopathy. Cancer Imaging 30:173-180
19. Robbins KT, Medina JE, Wolfe GT et al (1991) Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 117:601-605
20. Padhani AR, Ollivier L (2001) The RECIST (response evaluation criteria in solid tumors): implications for diagnostic radiologists. Br J Radiol 74: 983-986
21. Citrin D, Mansueti J, Likhacheva A et al (2009) Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced headand- neck cancer. Int J Radiat Oncol Biol Phys 74:1040-1046
22. Rapidis AD, Vermorken JB, Bourhis J (2008) Targeted therapies in head and neck cancer: past, present and future. Rev Recent Clin Trials 3:156-166
23. Yankeelov TE, Lepage M, Chakravarthy A et al (2007) Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 25:1-13
24. Moffat BA, Chenevert TL, Meyer CR et al (2006) The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia 8:259-267
25. Patterson DM, Padhani AR, Collins DJ (2008) Technology insight: water diffusion MRI-a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol 5:220-233
26. Kim H, Morgan DE, Zeng H et al (2008) Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosisinducing anti-DR5 antibody. Radiology 248:844-851
27. Seierstad T, Røe K, Olsen DR (2007) Noninvasive monitoring of radiationinduced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal tumor model. Radiother Oncol 85:187-194
28. Moffat BA, Chenevert TL, Lawrence TS et al (2005) Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 102:5524-5529
29. Kim S, Loevner L, Quon H et al (2009) Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 15:986-994
30. Harry VN, Semple SI, Gilbert FJ et al (2008) Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 111:213-220
31. Mardor Y, Pfeffer R, Spiegelmann R et al (2003) Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 21:1094-1100
32. Hamstra DA, Galbán CJ, Meyer CR et al (2008) Functional diffusion map as an early imaging biomarker for highgrade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol 26:3387-3394
33. Padhani AR, Liu G, Koh DM et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102-125
34. Thoeny HC, De Keyzer F, Vandecaveye V et al (2005) Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 237:492-499
35. Abdel Razek AA, Kandeel AY, Soliman N et al (2007) Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 28:1146-1152
36. King AD, Ahuja AT, Yeung DK et al (2007) Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology 245:806-813
37. Tozer DJ, Davies GR, Altmann DR et al (2006) Principal component and linear discriminant analysis of T1 histograms of white and gray matter in multiple sclerosis. Magn Reson Imaging 24:793-800
38. Brun E, Kjellén E, Tennvall J et al (2002) FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24(2):127-135
39. Dirix P, Vandecaveye V, De Keyzer F, et al (2009) Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: impact on radiotherapy planning. Int J Radiat Oncol Biol Phys 251:134-146